INTERPHEX Exhibitor Award Program

Submit Today

Sponsored by: Pharmaceutical Processing

IPX Exhibitor Award logo

Rewarding the Very Best in Knowledge, Innovation and State-of-the-Art Technologies at INTERPHEX

Exhibitor Awards

INTERPHEX is THE place to launch and/or showcase your new technologies, products or services. The annual INTERPHEX Exhibitor Awards were established to recognize companies that provide cutting-edge technologies and value-added solutions and services that enable pharma and bio development and manufacturing companies to achieve business and production goals and objectives with the ultimate goal of transforming critical and affordable life-enhancing ideas to cost effective, quality product.

Winners are awarded for showcasing innovative technologies and/or new strategies and services that have significantly improved pharma and bio development and manufacturing.

  • Submissions accepted January 3, 2017- February 11, 2017
  • Onsite Review of Exhibits: Tuesday, March 21 at 7:30am EST, INTERPHEX 2017 Show Floor
  • Announcement of Winners: Tuesday, March 21 at 9:45am EST, during the Opening Ceremony
  • Exhibitor Award meter boards will be placed at each Show Entrance and Winning Exhibit
  • See all the 2016 Award Winners

To win an INTERPHEX Exhibitor Award, the exhibit/booth must excel in each criterion, rise above your competitors, and clearly reflect excellence in pharma and biopharma development and manufacturing.

Pharmaceutical Processing will provide Editorial, Print, A/V Coverage, and Onsite Interviews

Award Categories

Best in Show
The Best in Show Award recognizes accomplishments and display in the use of knowledge, innovation, and state-of-the-art technologies to achieve extraordinary levels of quality, production goals, and objectives—ultimately transforming critical and affordable life-enhancing ideas to finished drug products.

Best New Product/Service
The Best New Product/Service Award is given to the exhibitor that encourages, develops, and features the very best in new products or services showcasing knowledge, innovation, and state-of-the-art technologies leading to significant business, economic, or manufacturing benefits for the pharma and bio industries.

Editor’s Choice (sponsored by Pharmaceutical Processing)
The Editor of Pharmaceutical Processing awards the Editor’s Choice Award, which is based upon her view of the best in exhibiting in Knowledge, Innovation, and Technologies within the pharma and biopharma industries.

Best Technologies Innovation
The Best Technologies Innovation Award recognizes cutting-edge technologies, either new technologies or a novel implementation of existing technologies, that has the potential to change the way pharma/bio companies operate.

INTERPHEX Efficiency Champion
The INTERPHEX Efficiency Champion Award is given to an exhibitor whose product or service understands the need for integrated efficiencies in processes and supports the fast pacing of the pharma/bio industry—whether in research, development, or commercial-scale production.

Biotech Innovation Award
The Biotech Innovation Award acknowledges an exhibitor’s innovative application to a given product or service that not only addresses an industry need, but does so in such a way as to exceed previous standards or applications—thereby making the given process simpler, smoother, or easier to navigate. ×

Judging Panel

The INTERPHEX Exhibitor Award Judging Panel has a very difficult task; selecting which exhibit is most deserving of an Exhibitor Award!

  • Meg Synder
    Meg Synder
    Editor
    Pharmaceutical Processing
    Bio
  • David Hall
    David Hall
    Vice President of Sales
    Parenteral Drug Association (PDA)
    Bio
  • Barry Holtz
    Barry Holtz
    Principal
    Holtz Biopharma Consulting
    Bio
  • Eric Jayjock
    Eric Jayjock, PhD
    Director of Continuous Manufacturing
    Patheon
    Bio
  • Dina Maines
    Dina Maines
    VP of Quality and Regulatory Affairs
    Elite Labs
    Bio
  • Christa Myers
    Christa Myers
    Associate, Lead Process Engineer
    CRB
    Bio
  • Gil Roth
    Gil Roth
    Founder, President
    Pharma & Biopharma Outsourcing Association
    Bio
  • Matthew VonEsch
    Matthew VonEsch
    Sr. Director, Manufacturing
    Sigma Tau PharmaSource
    Bio
×

Back

Meg Synder

Meg Synder

Meg Snyder is the Editor of Pharmaceutical Processing, and oversees the development of the editorial content for the print, web, and e-newsletter offerings. Since joining the Pharmaceutical Processing team, Meg has covered a variety of topics relevant to the pharmaceutical and biopharmaceutical industries, such as biosimilars, serialization and compliance efforts, supply chain concerns, injectables, single-use technologies, 3-D printing, and much more. Meg is a journalist and medical writer with a background in news features.

×

Back

Angelo DePalma, PhD

Angelo DePalma

Angelo DePalma, Ph.D., has been a healthcare industry writer for 25 years. His articles have appeared in dozens of print and online publications. He has also ghost-written articles for leading pharmaceutical, biotech, and supplier companies. DePalma holds a Ph.D. in organic chemistry. Before starting his writing services business he was Senior Scientist at Schering-Plough.

×

Back

David Hall

David Hall

David Hall is currently the Vice President of Sales for the Parenteral Drug Association (PDA). He has more than twenty-five years of association, sales, and trade show management experience within the pharmaceutical and biotechnology industries with a core focus on customer relationship building and strategic alliances. Mr. Hall has consistently developed and implemented innovative strategies to drive revenue and increase sales from advertising, exhibition and event sponsorship sales while creating value for clients.

×

Back

Barry Holtz

Barry Holtz

Dr. Holtz is the principal of Holtz Biopharma Consulting, a member of the Klyo Collaborative. He consults for pharma and bio-pharma companies in biologic therapeutics development, bioprocess design and facilities design and engineering. Dr. Holtz was the co-founder of five successful biotechnology companies including: Holtz Bioengineering, Large Scale Biology, InterveXion Therapeutics, G-CON Manufacturing and Caliber Biotherapeutics. Dr. Holtz has held research management positions at Foremost-Mckesson and was on the faculty of Ohio State University. He received his Ph.D. at Pennsylvania State University and was an NSF Postdoctoral Biochemist Fellow at Scripps Institution of Oceanography. Dr. Holtz has been awarded 24 US patents and has published over 65 scientific papers.

×

Back

Christa Myers

Christa Myers

Christa Myers is a Process Chemical Engineer with 20+ years of experience providing clients with insight as to how codes, past and current regulations and innovative technologies apply to their process and facility designs. Her involvement starts with the strategic concept and continues through construction and startup of projects. After project completion, Christa continues to evaluate whether the design elements worked properly, or should be re-evaluated further for future projects.

With an extensive background in the design of fill-finish facilities, chemical kilo labs, pilot plants, API research and manufacturing facilities, bulk pharmaceutical chemical facilities, highly hazardous compound containment, and biotech process facilities, Christa’s broad range of expertise benefits her clients in the design of their facilities. Her operating experience with a leading biotechnology and pharmaceutical company as a Process Engineer provides her with insight to the reality of daily operations.

Christa knows the difference between designing for the large pharmaceutical firms, the contract manufacturing organizations, and the generic companies. The business drivers that lead to decisions on capital budgets are different for each type of company. Even projects that are built around a single product have to take into consideration a base range of products since capital equipment typically has a life after the initial product run. Christa knows the right strategic questions to ask and address in order to ascertain the real needs of the equipment.

×

Back

Dina Maines

Dina Myers

Dina Maines is an industry veteran with a very broad experience and technical base. She began her career in the laboratory as a microbiologist, but then transitioned into production operations roles including solid oral dose manufacturing, granulation, coating, liquid product, and hard shell capsule manufacturing. She then moved forward into conventional packaging operations (bottle, blister and liquid), and ultimately headed up the transdermal manufacturing area for a major pharmaceutical company. She held responsibilities for two transdermal production operations areas and was vertically integrated as she also headed the converting operations for one of the laminate materials used in her manufacturing area. Dina ultimately transitioned from operations to Quality and Compliance roles in the mid 90’s. She has worked in the dietary supplement field and gained soft gelatin capsule manufacturing experience during that tenure. Since then she has had increasing levels of Quality and Compliance responsibility including a Vice President role, but since late 2012 has joined the support efforts for our industry via consultant opportunities.

With an extensive background in the design of fill-finish facilities, chemical kilo labs, pilot plants, API research and manufacturing facilities, bulk pharmaceutical chemical facilities, highly hazardous compound containment, and biotech process facilities, Christa’s broad range of expertise benefits her clients in the design of their facilities. Her operating experience with a leading biotechnology and pharmaceutical company as a Process Engineer provides her with insight to the reality of daily operations.

Dina brings a deep understanding of many methods of manufacturing, and an understanding of applied cGMP. She has headed a corporate compliance team, and has audited on behalf of many companies and clients, both domestic and international. Dina has worked with companies that are non-traditional suppliers of goods and services to bring them to a state of cGMP compliance. She has worked with start-up companies and put programs and processes in place to make the transition from R&D to commercial operations. She has filled Quality site head roles as a consultant, and most importantly has worked with companies under distress with response writing to regulatory comment and assessment and remediation activities for companies under regulatory action. She recently worked with a major pharmaceutical firm with their efforts to certify their corrections as part of FDA re-inspection readiness.

Dina has a bachelor degree in Microbiology from Rutgers University and an MBA from Fairleigh Dickinson University.

×

Back

Eric Jayjock

Eric Jayjock

Eric Jayjock performed his graduate studies at Rutgers University where he was a part of the NSF Center for Structured Organic Particulate (C-SOPS) systems. During his time at Rutgers, one of his main areas of research was the development of scalable manufacturing processes for oral solids dosages. As a culmination of this work he designed and coordinated the construction of the C-SOPS continuous direct Compression line in collaboration with Janssen, a Johnson & Johnson company. Upon the completion of this work Eric join the Janssen team and worked on bringing the continuous manufacturing approach to the industry. More recently, Eric has joined Patheon where he is focused on developing highly flexible, highly capable continuous manufacturing framework to serve the diverse needs of the Pharmaceutical Industry.

×

Back

Gil Roth

Gil Roth

Gil Roth is the founder and president of the Pharma & Biopharma Outsourcing Association (PBOA), a nonprofit trade association for Contract Manufacturing Organizations (CMO) and Contract Development and Manufacturing Organizations (CDMO). In 1999, he helped launch Contract Pharma , which swiftly became the premier magazine covering the outsourcing and contract services industry. He served as editor from October 1999 until February 2014, chronicling the evolution of the pharmaceutical outsourcing sector. He also helped build Contract Pharma’s annual Contracting & Outsourcing Conference & Exhibition into a top-tier event for both contract service providers and their clients. In 2013, while reporting on an article about the Generic Drug User Fee Amendments (GDUFA), Mr. Roth had the idea to build a trade association (PBOA) for CMOs and CDMOs, in order to provide a voice in regulatory and legislative areas and to raise awareness of the pivotal role they play in healthcare. Gil Roth received a B.A. from Hampshire College and a M.A.L.A. from St. John’s College. He was an associate editor and managing editor for several business-to-business magazines before becoming the founding editor of Contract Pharma, a role he held for nearly 15 years.

×

Back

Matthew VonEsch

Matthew VonEsch

Matthew VonEsch is the Senior Director of Manufacturing at Sigma Tau PharmaSource and is responsible for internal/external aspects of manufacturing the company’s sterile product portfolio, including large molecule bulk drug substance manufacturing, sterile drug product manufacturing, bulk, final labeling/packaging, validation, technical support, and Facilities/Maintenance.

×

Criteria

The judges will evaluate each submitting exhibitors booth based on the following criteria:

  • Overall Appeal/Experience (Design)
  • Knowledge (Content)
  • Product/Service Innovation
  • New Technologies or Novel Implementation of Existing Technologies
  • Advances in Features and Performance
  • Development of Novel Technologies
  • Novel Implementation of Existing Technologies
  • Advances in Services Provision
  • Significant New Services Additions
  • Showcasing of Technical Knowledge

Eligibility

  • All INTERPHEX Exhibitors are eligible
  • Previous INTERPHEX Exhibitor Award winners are eligible if their current, nominated exhibits/booth has never received an award
  • Self and peer nominations are accepted, and agencies are encouraged to submit entries on behalf of their clients
  • Submissions of copied press releases will not be accepted
×

Winning Benefits include:

  • Increased Booth Traffic
    • Signage of Award Winners placed at all show entrances
    • Each Award Winner will receive meter board signage denoting the achievement
  • Press Release Announcing Winners
  • Recognition and Awards announced during Opening Ceremony
  • Trophy Recognizing Each Award Winner
  • Inclusion in INTERPHEX and Pharmaceutical Processing Show and Post-Show Coverage to Maximize Exposure
  • INTERPHEX Social Media
  • INTERPHEX and Pharmaceutical Processing websites to maximize exposure
×

Previous Winners

2016 Winners

Best in Show:GE Healthcare Life Sciences
GE Healthcare Life Sciences was recognized for KUBio™, a prefabricated cGMP-compliant facility and process solution designed for the scalable and cost-efficient production of monoclonal antibodies (mAbs). Prevalidated modular units and processing equipment are transported to a specified site. They are assembled on site, and the resulting facility is qualified and ready-to-run within 14 to 18 months. To learn more about this technology, visit booth 3141.

Best New Product/Service: Nemera
Nemera was recognized for Novelia® BFS, a preservative-free multi-dose eyedropper combined with bottlepack® technology. Novelia® works with high viscosity suspensions and solutions of up to 1500 cps and limits the distribution of liquids to one drop at a time. The doses of the drops are precise, which intended to assist medication adherence. To learn more about this technology, visit booth 1636.

Editor’s Choice: Catalent Pharma Solutions
Catalent Pharma Solutions was recognized for OptiForm® Solution Suite, a detailed molecule assessment with high throughput screening and parallel assessment of formulation technologies. It is designed to help solve complex bioavailability challenges for early stage molecules using a unique toolkit of bioavailability enhancing technologies. OptiForm® Solution Suite matches the best formulation technologies to a molecule and utilizes an accelerated parallel screening and development approach. To learn more about this technology, visit booth 1546.

Best Technological Innovation: Videojet Technologies
Videojet Technologies was recognized for Videojet® 7510 50-Watt Fiber Laser Marker, a laser marking system with high contrast marking on robust plastic packaging, metal containers, as well as other industrial products. Operating on speeds on to 440m/min., this technology delivers better mark quality and has a smaller marking unit, compared to traditional solid state laser systems. To learn more about this technology, visit booth 2725.

Efficiency Champion [NEW]: Millipore Sigma
Millipore Sigma was recognized for Mobius® 1000 L Single-Use Bioreactor, a stirred tank bioreactor that configures software, hardware, and single-use assemblies for use in suspension and adherent cell culture applications. It functions as a standalone system or integrated as part of a facility’s automation platform. To learn more about this technology, visit booth 2841.

Biotech Innovation Award [NEW]: Bausch + Stroebel
Bausch + Stroebel was recognized for VarioSys®, a flexible processing line based on the lock-and-key principle. This pharmaceutical production system features a flexible pharmaceutical/biotechnological processing line, modular design, and standardization of subassemblies. In a special isolator enabling production in clean room class A conditions, individual production modules can be installed that fit on the lock-and-key principle—for instance, a machine for processing syringes in nests or a filling and closing machine for vials. To learn more about this technology, visit booth 2505B.

2015 Winners

Best in Show — Pall Life Sciences
Pall Life Sciences was recognized for their new Cadence™ single-pass tangential flow filtration (SPTFF) technology that uses a staged flow path design to achieve significantly higher concentration factors (2-4x or greater) in one pump pass than is possible with conventional TFF systems that include a recirculation loop. The key innovation offered by the Cadence single-pass tangential flow filtration (SPTFF) technology is the ability to achieve the significant concentration of downstream biopharmaceutical process streams in a single pass without the need for recirculation. With this technology, smaller volumes, higher titers and higher product recoveries are achieved compared with those possible with conventional TFF systems.

Honorable Mention, Best in Show — GE Healthcare Life Sciences AxiChrom
GE Healthcare Life Sciences was recognized for the AxiChrom column platform, a revolutionary concept in column chromatography that has been extended to feature new 1.2 and 1.6m columns to overcome many of the challenges related to increasing column size. AxiChrom columns help reduce operation time with its automated packing methods. But the intelligence of AxiChrom goes beyond automation: its purposeful design enables excellent chromatographic performance through its axial compression capabilities and distribution system properties. The innovation of the new AxiChrom columns are scaled-up manufacturing and many time-saving features.

Best New Product/Service — Apprentice Field Suite
Apprentice Field Suite is awarded Best New Product/Service for the Apprentice Field Suite, trio of applications exclusively for Smart Glasses that empowers biopharmaceutical manufacturing operators and engineers to help them make informed decisions. The three applications, TANDEM, MANUALS and GAUGE, leverage Augmented Reality, Computer Vision, Telepresence, and the Myo Armband to provide essential data, process and workflow aids, and sophisticated troubleshooting interfaces. TANDEM, was developed as a way for remote engineers to view exactly what operators are seeing in the manufacturing suite. This greatly improves communication and speeds up the troubleshooting process. MANUALS, is able to interface with companies existing standard operating procedures, batch records, job plans and more. The biggest innovations come from GAUGE. This computer vision software automatically reads and saves analog gauge values, and can warn operators about which bioreactor is still in use prior to cleaning the vessel.

Editor’s Choice Award (sponsored by Pharmaceutical Processing) — Fette Compacting
Fette Compacting is recognized for its entire FE series of tablet presses, displayed together for the first time at the same show. Headlined by the North American debut of the FE75 double-sided press, other models include the FE55 and FE35. The core design philosophy threading its way through the FE series is that of Fette’s Tri.Easy concept. Tri.Easy represents the simplification of the three primary aspects of tablet press use-those of changeover, operation and maintenance. The FE75 is an ultra-high-speed, double-sided tablet press with superlative capabilities featuring three manufacturing modes: mono-layer manufacturing, with double-sided discharge; direct compression for difficult products; and double-layer manufacturing, with single-sided discharge. The FE series fulfills the unique requirement of providing presses that can produce an ever greater number of tablets, while occupying less space on the manufacturing floor while simultaneously providing users with the technological versatility for compressing an overwhelming majority of potential tablets on one press.

Best Technologies Innovation — G-CON Manufacturing, GEA and Pfizer
G-Con Manufacturing is recognized for the Portable, Continuous, Miniature and Modular (PCMM) platform. PCMM is a standardized production technology platform used for product development and commercial manufacturing offering a process analytical technology (PAT)-compatible process control solution for continuous wet granulation and continuous mixing/direct compression, enabling efficient transfer from development to clinical and commercial production without scale-up that is easy to deploy and ship. A key advantage is being able to use the same equipment throughout the entire product lifecycle. In addition, the PCMM platform combines equipment design, PAT, advanced process control and engineering expertise to deliver a fully integrated cGMP facility using PODs. This first-of-a-kind system has the potential to transform the future of pharmaceutical process development and manufacturing while providing the flexibility needed to address the evolving portfolio requirements for in-country and small-lot manufacturing.

×

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.